Search research articles
Contact Us
Filters
Showing results (211-220 of 227) with videos related to
Page
of 23
Sort By:
Nature Medicine
|
October 3, 2017
Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis
Rodrigo Romero, Volkan I Sayin, Shawn M Davidson, et al.
Nature Communications
|
June 28, 2023
A landscape of response to drug combinations in non-small cell lung cancer
Nishanth Ulhas Nair, Patricia Greninger, Xiaohu Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 29, 2014
High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells
Lesley A Mathews Griner, Rajarshi Guha, Paul Shinn, et al.
Cancer Letters
|
June 25, 2023
Drug combinations identified by high-throughput screening promote cell cycle transition and upregulate Smad pathways in myeloma
Tyler J Peat, Snehal M Gaikwad, Wendy Dubois, et al.
Blood Cancer Discovery
|
November 15, 2021
Overcoming Acquired Epigenetic Resistance to BTK Inhibitors
Arthur L Shaffer, James D Phelan, James Q Wang, et al.
ACS Medicinal Chemistry Letters
|
February 14, 2012
Diversity-Oriented Synthesis Yields a Novel Lead for the Treatment of Malaria
Richard W Heidebrecht, Carol Mulrooney, Christopher P Austin, et al.
Molecular Cancer Therapeutics
|
October 14, 2024
Targeting NAD+ Metabolism Vulnerability in FH-Deficient Hereditary Leiomyomatosis and Renal Cell Carcinoma with the Novel NAMPT Inhibitor OT-82
Susana S Najera, Christopher J Ricketts, Laura S Schmidt, et al.
Science Translational Medicine
|
November 22, 2019
Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening
Grant L Lin, Kelli M Wilson, Michele Ceribelli, et al.
Cancer Cell
|
December 16, 2010
Cooperative epigenetic modulation by cancer amplicon genes
Lixin Rui, N C Tolga Emre, Michael J Kruhlak, et al.
The New England Journal of Medicine
|
June 20, 2024
Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma
Christopher Melani, Rahul Lakhotia, Stefania Pittaluga, et al.
Page
of 23
Search research articles
Search
Showing results (211-220 of 227) with videos related to
Sort By:
Page
of 23
Nature Medicine
|
October 3, 2017
Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis
Rodrigo Romero, Volkan I Sayin, Shawn M Davidson, et al.
Nature Communications
|
June 28, 2023
A landscape of response to drug combinations in non-small cell lung cancer
Nishanth Ulhas Nair, Patricia Greninger, Xiaohu Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 29, 2014
High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells
Lesley A Mathews Griner, Rajarshi Guha, Paul Shinn, et al.
Cancer Letters
|
June 25, 2023
Drug combinations identified by high-throughput screening promote cell cycle transition and upregulate Smad pathways in myeloma
Tyler J Peat, Snehal M Gaikwad, Wendy Dubois, et al.
Blood Cancer Discovery
|
November 15, 2021
Overcoming Acquired Epigenetic Resistance to BTK Inhibitors
Arthur L Shaffer, James D Phelan, James Q Wang, et al.
ACS Medicinal Chemistry Letters
|
February 14, 2012
Diversity-Oriented Synthesis Yields a Novel Lead for the Treatment of Malaria
Richard W Heidebrecht, Carol Mulrooney, Christopher P Austin, et al.
Molecular Cancer Therapeutics
|
October 14, 2024
Targeting NAD+ Metabolism Vulnerability in FH-Deficient Hereditary Leiomyomatosis and Renal Cell Carcinoma with the Novel NAMPT Inhibitor OT-82
Susana S Najera, Christopher J Ricketts, Laura S Schmidt, et al.
Science Translational Medicine
|
November 22, 2019
Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening
Grant L Lin, Kelli M Wilson, Michele Ceribelli, et al.
Cancer Cell
|
December 16, 2010
Cooperative epigenetic modulation by cancer amplicon genes
Lixin Rui, N C Tolga Emre, Michael J Kruhlak, et al.
The New England Journal of Medicine
|
June 20, 2024
Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma
Christopher Melani, Rahul Lakhotia, Stefania Pittaluga, et al.
Page
of 23